Two oral HBx vaccines delivered by live attenuated Salmonella: Both eliciting effective anti-tumor immunity

Cancer Letters

Volumn 263, Issue 1, 2008, Pages 67-76

  Wang, Ye Jun ^a   Hou, Yan ^b   Huang, He ^a   Liu, Gui Rong ^a,c   White, Aaron P ^c   Liu, Shu Lin ^a,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anti tumor immunity; Hepatitis B virus x gene (HBx); Salmonella; Tumor vaccine; Type III secretion system (TTSS)

Indexed keywords

HYBRID PROTEIN; TUMOR VACCINE;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG USE; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GROWTH RATE; HEPATITIS B VIRUS; IMMUNE RESPONSE; MELANOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SALMONELLA; T LYMPHOCYTE ACTIVATION; TUMOR VOLUME; VACCINE PRODUCTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CLONING, MOLECULAR; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B VACCINES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALMONELLA; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANS-ACTIVATORS;

ANIMALIA; EUKARYOTA; HEPATITIS B VIRUS; MUS; PROKARYOTA; SALMONELLA;

EID: 41049092065     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.12.022     Document Type: Article

References (34)

1. Samuelson P., Gunneriusson E., Nygren P.A., and Stahl S. Display of proteins on bacteria. J. Biotechnol. 96 2 (2002) 129-154
2. Spreng S., Dietrich G., and Weidinger G. Rational design of Salmonella-based vaccination strategies. Methods 38 2 (2006) 133-143
3. Siebers A., and Finlay B.B. M cells and the pathogenesis of mucosal and systemic infections. Trends Microbiol. 4 1 (1996) 22-29
4. Kubori T., and Galan J.E. Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115 3 (2003) 333-342
5. Darji A., Guzman C.A., Gerstel B., Wachholz P., Timmis K.N., Wehland J., Chakraborty T., and Weiss S. Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 91 6 (1997) 765-775
6. Xiang R., Lode H.N., Chao T.H., Ruehlmann J.M., Dolman C.S., Rodriguez F., Whitton J.L., Overwijk W.W., Restifo N.P., and Reisfeld R.A. An autologous oral DNA vaccine protects against murine melanoma. Proc. Natl. Acad. Sci. USA 97 10 (2000) 5492-5497
7. Marlovits T.C., Kubori T., Sukhan A., Thomas D.R., Galan J.E., and Unger V.M. Structural insights into the assembly of the type III secretion needle complex. Science 306 5698 (2004) 1040-1042
8. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62 2 (1998) 379-433
9. Russmann H., Kubori T., Sauer J., and Galan J.E. Molecular and functional analysis of the type III secretion signal of the Salmonella enterica InvJ protein. Mol. Microbiol. 46 3 (2002) 769-779
10. Stebbins C.E., and Galan J.E. Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion. Nature 414 6859 (2001) 77-81
11. Karavolos M.H., Roe A.J., Wilson M., Henderson J., Lee J.J., Gally D.L., and Khan C.M. Type III secretion of the Salmonella effector protein SopE is mediated via an N-terminal amino acid signal and not an mRNA sequence. J. Bacteriol. 187 5 (2005) 1559-1567
12. Guiney D.G., and Lesnick M. Targeting of the actin cytoskeleton during infection by Salmonella strains. Clin. Immunol. 114 3 (2005) 248-255
13. Coombes B.K., Brown N.F., Valdez Y., Brumell J.H., and Finlay B.B. Expression and secretion of Salmonella pathogenicity island-2 virulence genes in response to acidification exhibit differential requirements of a functional type III secretion apparatus and SsaL. J. Biol. Chem. 279 48 (2004) 49804-49815
14. Nikolaus T., Deiwick J., Rappl C., Freeman J.A., Schroder W., Miller S.I., and Hensel M. SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon. J. Bacteriol. 183 20 (2001) 6036-6045
15. Russmann H., Shams H., Poblete F., Fu Y., Galan J.E., and Donis R.O. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281 5376 (1998) 565-568
16. Evans D.T., Chen L.M., Gillis J., Lin K.C., Harty B., Mazzara G.P., Donis R.O., Mansfield K.G., Lifson J.D., Desrosiers R.C., et al. Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system. J. Virol. 77 4 (2003) 2400-2409
17. Shams H., Poblete F., Russmann H., Galan J.E., and Donis R.O. Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. Vaccine 20 3-4 (2001) 577-585
18. Russmann H., Igwe E.I., Sauer J., Hardt W.D., Bubert A., and Geginat G. Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins. J. Immunol. 167 1 (2001) 357-365
19. Kotton C.N., Lankowski A.J., Scott N., Sisul D., Chen L.M., Raschke K., Borders G., Boaz M., Spentzou A., Galan J.E., et al. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system. Vaccine 24 37-39 (2006) 6216-6224
20. Panthel K., Meinel K.M., Domenech V.E., Retzbach H., Igwe E.I., Hardt W.D., and Russmann H. Salmonella pathogenicity island 2-mediated overexpression of chimeric SspH2 proteins for simultaneous induction of antigen-specific CD4 and CD8 T cells. Infect. Immun. 73 1 (2005) 334-341
21. Chisari F.V., and Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13 (1995) 29-60
22. Bouchard M.J., Wang L., and Schneider R.J. Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J. Virol. 80 9 (2006) 4406-4414
23. Kim C.M., Koike K., Saito I., Miyamura T., and Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351 6324 (1991) 317-320
24. Benn J., and Schneider R.J. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc. Natl. Acad. Sci. USA 92 24 (1995) 11215-11219
25. Tang H., Oishi N., Kaneko S., and Murakami S. Molecular functions and biological roles of hepatitis B virus x protein. Cancer sci. 97 10 (2006) 977-983
26. *0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization. J. Immunol. 165 8 (2000) 4748-4755
27. * 0201-restricted T-cell epitopes of HBx antigen of hepatitis B virus. Microbes Infect. 7 4 (2005) 626-634
28. Chun E., Lee J., Cheong H.S., and Lee K.Y. Tumor eradication by hepatitis B virus X antigen-specific CD8+ T cells in xenografted nude mice. J. Immunol. 170 3 (2003) 1183-1190
29. Liu S.L., and Sanderson K.E. A physical map of the Salmonella typhimurium LT2 genome made by using XbaI analysis. J. Bacteriol. 174 5 (1992) 1662-1672
30. Zhang H., Wang W., Li Q., and Huang W. Fusion protein of ATPase domain of Hsc70 with TRP2 acting as a tumor vaccine against B16 melanoma. Immunol. Lett. 105 2 (2006) 167-173
31. Vollmer Jr. C.M., Eilber F.C., Butterfield L.H., Ribas A., Dissette V.B., Koh A., Montejo L.D., Lee M.C., Andrews K.J., McBride W.H., et al. Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma. Cancer Res. 59 13 (1999) 3064-3067
32. Curtiss III R., Galan J.E., Nakayama K., and Kelly S.M. Stabilization of recombinant avirulent vaccine strains in vivo. Res. Microbiol. 141 7-8 (1990) 797-805
33. White A.P., Collinson S.K., Burian J., Clouthier S.C., Banser P.A., and Kay W.W. High efficiency gene replacement in Salmonella enteritidis: Chimeric fimbrins containing a T-cell epitope from Leishmania major. Vaccine 17 17 (1999) 2150-2161
34. Bu X.X., White A.P., Wang L., and Liu S.L. Salmonella fimbriae-based vaccine vector for expressing foreign genes. Chinese J. Microbiol. Immunol. 26 (2006) 974-978